Pulmonx Corporation (LUNG) Tops Q2 EPS by 2c
Get Alerts LUNG Hot Sheet
Join SI Premium – FREE
Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $23.86 million versus the consensus estimate of $23.47 million.
For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ScanSource (SCSC) Misses Q1 EPS by 25c ; Offers Guidance
- Castle Brands (ROX) Tops Q4 EPS by 388c ; Provides EPS range
- Climb Bio, Inc. (CLYM) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share